217 related articles for article (PubMed ID: 17680952)
1. Human erythrovirus B19 and blood transfusion - an update.
Parsyan A; Candotti D
Transfus Med; 2007 Aug; 17(4):263-78. PubMed ID: 17680952
[TBL] [Abstract][Full Text] [Related]
2. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
[TBL] [Abstract][Full Text] [Related]
3. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals.
Doyle S; Corcoran A
J Infect Dis; 2006 Jul; 194(2):154-8. PubMed ID: 16779720
[TBL] [Abstract][Full Text] [Related]
4. [Safety of blood products and B19 parvovirus].
Lefrère JJ; Maniez-Montreuil M; Morel P; Defer C; Laperche S
Transfus Clin Biol; 2006 Oct; 13(4):235-41. PubMed ID: 16822687
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
6. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus.
Bonvicini F; Gallinella G; Cricca M; Ambretti S; Delbarba S; Musiani M; Zerbini M
J Med Virol; 2004 Oct; 74(2):272-6. PubMed ID: 15332276
[TBL] [Abstract][Full Text] [Related]
7. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates.
Schalasta G; Schmid M; Lachmund T; Enders G
J Med Virol; 2004 May; 73(1):54-9. PubMed ID: 15042648
[TBL] [Abstract][Full Text] [Related]
8. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products.
Plentz A; Hahn J; Knöll A; Holler E; Jilg W; Modrow S
Transfusion; 2005 Nov; 45(11):1811-5. PubMed ID: 16271109
[TBL] [Abstract][Full Text] [Related]
9. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
10. Erythrovirus B19 infection in humans.
Kishore J; Kapoor A
Indian J Med Res; 2000 Nov; 112():149-64. PubMed ID: 12452123
[TBL] [Abstract][Full Text] [Related]
11. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
Kishore J; Mukhopadhyay C
Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
[TBL] [Abstract][Full Text] [Related]
12. Parvovirus B19 transmission by a high-purity factor VIII concentrate.
Wu CG; Mason B; Jong J; Erdman D; McKernan L; Oakley M; Soucie M; Evatt B; Yu MY
Transfusion; 2005 Jun; 45(6):1003-10. PubMed ID: 15935000
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009.
Kooistra K; Mesman HJ; de Waal M; Koppelman MH; Zaaijer HL
Vox Sang; 2011 Apr; 100(3):261-6. PubMed ID: 20946549
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
15. Blood donor screening for parvovirus B19 in Germany and Austria.
Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
[TBL] [Abstract][Full Text] [Related]
16. Maternal-fetal transmission of human parvovirus B19 genotype 3.
Candotti D; Danso K; Parsyan A; Dompreh A; Allain JP
J Infect Dis; 2006 Sep; 194(5):608-11. PubMed ID: 16897659
[TBL] [Abstract][Full Text] [Related]
17. [Parvovirus B19 infection].
Araújo F; Koch MC; Monteiro F; Araújo AR
Acta Med Port; 1999; 12(4-6):195-202. PubMed ID: 10481322
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil.
Freitas RB; Melo FL; Oliveira DS; Romano CM; Freitas MR; Macêdo O; Linhares AC; de A Zanotto PM; Durigon EL
J Clin Virol; 2008 Sep; 43(1):60-5. PubMed ID: 18502682
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
20. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.
Donoso Mantke O; Nitsche A; Meyer R; Klingel K; Niedrig M
J Clin Virol; 2004 Sep; 31(1):32-9. PubMed ID: 15288611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
